Tab Application Banner
  • Users Online: 658
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Ahead of Print

Bye-bye muscle biopsy, we have autoantibodies with us now

1 Department of Biology and Biochemistry, University of Bath, Bath, England, UK
2 Department of Pharmacy and Pharmacology, University of Bath, Bath, England, UK

Correspondence Address:
Sarah L Tansley,
University of Bath, Bath
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/injr.injr_114_20

Muscle biopsy is generally considered the gold standard diagnostic tool for patients with presenting with features suggestive of idiopathic inflammatory myopathy. Muscle biopsy is however an invasive test, the histopathological findings can be influenced by previous treatment and not all patients with myositis spectrum disease have muscle involvement. Myositis specific and associated autoantibodies can now be identified in the majority of patients with myositis. When present they identify homogeneous patient subgroups and have the potential to be key tools in developing a personalised approach to disease management. Here we review the utility of myositis specific and associated autoantibodies as diagnostic and prognostic tools.

Print this article
  Search Pubmed for
    -  Riddell V
    -  Tansley SL
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded18    

Recommend this journal